D05.02 Lobular carcinoma in situ of left breast

Name of the Condition

• Lobular carcinoma in situ of left breast
• Often referred to as "LCIS of the left breast" or "lobular neoplasia of the left breast."

Summary

Lobular carcinoma in situ (LCIS) of the left breast is a non-invasive condition where abnormal cells are found in the lobules (milk-producing glands) of the left breast. It is not considered true cancer but indicates an increased risk of developing invasive breast cancer in either breast. LCIS is typically detected incidentally during a biopsy performed for another reason.

Causes

The exact cause of LCIS is not fully understood, but it involves genetic changes in the cells of the breast lobules. Hormonal factors and genetic predispositions may contribute to its development.

Risk Factors

• Female gender, particularly premenopausal or perimenopausal women.
• Family history of breast cancer.
• Genetic mutations, such as in the BRCA1 or BRCA2 genes.
• Prior history of benign breast conditions, like atypical lobular hyperplasia.

Symptoms

LCIS usually does not cause symptoms and is often found during a biopsy for an unrelated breast issue. Rarely, it may be associated with a lump or other breast changes, but these are uncommon.

Diagnosis

LCIS is diagnosed through a breast biopsy, typically performed after an abnormal finding on a mammogram, ultrasound, or MRI. A pathologist examines the tissue to confirm the presence of abnormal lobular cells.

Treatment Options

• Active Surveillance: Regular monitoring with mammograms and clinical exams, as LCIS is non-invasive and may not require immediate treatment.
• Risk-Reducing Medications: Tamoxifen or raloxifene may be prescribed to lower the risk of future invasive cancer.
• Prophylactic Surgery: Bilateral mastectomy is an option for high-risk individuals, though not routinely recommended for LCIS alone.

Prognosis and Follow-Up

LCIS itself does not spread or become life-threatening, but it increases the risk of invasive breast cancer. Follow-up typically includes annual mammograms and clinical breast exams. The risk remains elevated for life, so ongoing monitoring is essential.

Complications

The primary complication is the increased risk of developing invasive breast cancer in either breast. LCIS does not typically cause physical symptoms or complications on its own.

Lifestyle & Prevention

• Maintain a healthy weight and engage in regular physical activity.
• Limit alcohol consumption.
• Discuss family history and genetic testing with a healthcare provider to assess risk.
• Follow recommended breast cancer screening guidelines.

When to Seek Professional Help

Consult a healthcare provider if you notice a new lump, skin changes, or discharge from the breast, or if you have concerns about your breast cancer risk.

Tips for Medical Coders

Use code D05.02 for lobular carcinoma in situ of the left breast. Ensure documentation specifies the left breast and confirms the non-invasive nature of the condition. Differentiate from invasive lobular carcinoma (which uses a different code set) and other in situ breast conditions.